20776-60-7 Usage
Description
2-Amino-5,6-dichlorobenzoic acid is a chemical compound that belongs to the class of benzoic acids. It is a derivative of benzoic acid, characterized by the presence of two chlorine atoms at the fifth and sixth carbon atoms, and an amino group at the second carbon atom. 2-AMINO-5,6-DICHLOROBENZOIC ACID is often utilized as an intermediate in the synthesis of pharmaceuticals and agrochemicals, and serves as a reagent in various chemical reactions for research purposes. Due to its potentially hazardous nature, it requires careful handling with appropriate safety measures.
Uses
Used in Pharmaceutical Industry:
2-Amino-5,6-dichlorobenzoic acid is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Amino-5,6-dichlorobenzoic acid is employed as an intermediate in the production of agrochemicals, potentially enhancing crop protection and management through the development of new compounds.
Used in Research Applications:
2-Amino-5,6-dichlorobenzoic acid is used as a reagent in research for its role in facilitating various chemical reactions, contributing to the advancement of scientific knowledge and the discovery of novel chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 20776-60-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,7,7 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 20776-60:
(7*2)+(6*0)+(5*7)+(4*7)+(3*6)+(2*6)+(1*0)=107
107 % 10 = 7
So 20776-60-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H5Cl2NO2/c8-3-1-2-4(10)5(6(3)9)7(11)12/h1-2H,10H2,(H,11,12)
20776-60-7Relevant articles and documents
FUSED-RING PYRIMIDIN-4(3H)-ONE DERIVATIVES, PROCESSES FOR THE PREPARATION AND USES THEREOF
-
Page 348, (2010/02/06)
AbstractNovel compounds of the following formula (I) and pharmacologically acceptable salt and esters thereof can modulate LXR function and as a result show excellent anti-arteriosclerotic and anti-inflammatory activity:wherein:A represents aryl or heteroaryl;R1, R2 and R3 are the same or different and each represents hydrogen, hydroxyl, nitro, cyano, amino, halogen, carboxy, carbamoyl, mercapto, alkyl, haloalkyl, alkylcarbonyloxy, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonylamino, N-(alkylcarbonyl)-N-(alkyl)amino, alkoxycarbonylamino, N-(alkoxycarbonyl)-N-(alkyl)amino, alkylsulfonylamino, N-(alkylsulfonyl)-N-(alkyl)amino, haloalkylsulfonylamino, N-(haloalkylsulfonyl)-N-(alkyl)amino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group, or R1 and R2 together are alkylenedioxy;R4 and R5 are the same or different and each represents hydrogen, hydroxyl, amino, halogen, mercapto, alkyl, haloalkyl, alkoxy, alkoxycarbonyl or alkylthio;X represents hydrogen, hydroxyl, halogen, alkoxy or haloalkoxy; andY represents an optionally substituted alkyl, cycloalkyl, heterocyclyl, aryl, cycloalkylalkyl, heterocyclylalkyl or aralkyl group.
Alkyl 5,6-dichloro-3,4-dihydro-2(1H)-iminoquinazoline-3-acetate hydrohalides
-
, (2008/06/13)
The known blood platelet antiaggregative agent 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one is prepared in high yield via an improved process involving a novel intermediate of the Formula STR1 in which R1 is (lower)alkyl and X is bromo, chloro or iodo. Two processes for the preparation of compounds of the Formula III are disclosed, one of which involves the novel intermediate STR2
